Views & Analysis

Oncology
Henar Hevia and Carolyn Sousa at ASCO 2024

ASCO 2024 - Henar Hevia and Carolyn Sousa

The future of cancer care is personalisation. New breakthroughs are increasingly highly targeted, with powerful results, but only for patients with particular genetic markers.

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

Oncology
ASCO24

Four takeaways from ASCO24

Last weekend, I travelled to Chicago for the annual conference of the American Society of Clinical Oncologists— the annual event where major breakthroughs in cancer care are announced.

Oncology
diversity in clinical trials

Building resilience in cancer trials

Clinical trials are a cornerstone of oncology research, vital for turning scientific breakthroughs into effective cancer treatments.

Oncology
ASCO Mohit Manrao feature

ASCO 2024 - Mohit Manrao

Just about everyone seems to agree that the runaway success story of ASCO this year is AstraZeneca, with plenary sessions for the sixth year in a row and